https://european-biotechnology.net/wp-content/uploads/2025/10/Howard-Lutnick-_United-States-secretary-of-commerce-796x1030-1.jpg1030796Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-10-01 21:51:162025-10-10 11:02:03Pharma Tariffs: US Government backtracks
https://european-biotechnology.net/wp-content/uploads/2025/09/Revyve_team-e1758687129400.jpg282500Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-09-24 04:12:312025-09-24 04:12:31Revyve scaling up production by €24m financing
https://european-biotechnology.net/wp-content/uploads/2025/09/GenfitHQ_MAES-AREA-Englos-e1758436555810.jpg507900Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2025-09-21 06:46:572025-09-23 09:32:03Genfit SA discontinues lead programme